載入...
Atorvastatin 10 mg plus ezetimibe versus titration to atorvastatin 40 mg: attainment of European and Canadian guideline lipid targets in high-risk subjects ≥65 years
BACKGROUND: Few clinical studies have focused on the efficacy of lipid-lowering therapies in patients ≥65 years. METHODS: After stabilization on atorvastatin 10 mg, hypercholesterolemic subjects ≥65 years at high/very high risk for CHD and not at LDL-C <1.81 mmol/L (with atherosclerotic vascular...
Na minha lista:
Main Authors: | , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
BioMed Central
2014
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3901347/ https://ncbi.nlm.nih.gov/pubmed/24411003 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-511X-13-13 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|